Compare Booking Holdings Inc (BKNG) vs Cassava Sciences Inc (FLNA) Price & Performance

Booking Holdings (BKNG) trades at $209.92, down 1.39% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong Q2 2026 results, beating EPS estimates with $2.54 versus $2.43 expected, and maintains robust profitability with a 25.53% net income margin. Revenue growth continues, reaching $26.92B in 2025, supported by resilient travel demand.

The outlook remains positive with a consensus price target of $239.31, implying 14% upside, though risks include geopolitical volatility and rising debt levels. Analyst sentiment is strongly bullish with 64% buy ratings, while institutional interest is growing, as seen in recent filings. Earnings momentum and free cash flow generation support the investment case, but investors should monitor debt-to-asset trends and competitive pressures.

FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.

The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.